Literature DB >> 10464129

Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa.

A Nakazawa1, M Watanabe, T Kanai, T Yajima, M Yamazaki, H Ogata, H Ishii, M Azuma, T Hibi.   

Abstract

BACKGROUND & AIMS: Costimulatory signals are essential for T-cell activation. The aim of this study was to demonstrate expression of costimulatory molecules CD86 and CD80 in human colonic epithelial cells and assess their functional roles in the activation of T cells in inflamed colonic mucosa.
METHODS: CD86 and CD80 expression was assessed by immunohistochemistry of colonic mucosa, reverse-transcription polymerase chain reaction, and flow cytometric analysis of isolated colonic epithelial cells and cell lines. Costimulatory effect of CD86-expressing colonic epithelial cells on purified CD4(+) T-cell proliferation was also assessed at suboptimal phytohemagglutinin stimulation.
RESULTS: CD86 and CD80 messenger RNA was detected in isolated colonic epithelial cells from normal and inflamed mucosa of patients with ulcerative colitis. Immunohistochemistry and flow cytometric analysis of colonic epithelial cells confirmed cell surface expression of CD86 protein in inflamed colonic mucosa. Cell surface expression of CD86 protein was increased in the colonic epithelial cell line HT29-18-N2 after interferon gamma stimulation. Purified CD4(+) T cells proliferated in response to suboptimal phytohemagglutinin costimulated with interferon gamma-stimulated HT29-18-N2, and these proliferative responses were efficiently inhibited by the addition of anti-CD86 monoclonal antibody. Costimulatory effect of CD86-expressing colonic epithelial cells isolated from inflamed mucosa of ulcerative colitis was also demonstrated at suboptimal phytohemagglutinin stimulation in CD4(+) T cells.
CONCLUSIONS: Colonic epithelial cells may act as antigen-presenting cells, and contribute to the activation of T cells through costimulatory molecule CD86 expression in inflamed colonic mucosa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464129     DOI: 10.1016/s0016-5085(99)70446-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Colonic epithelial cell mediated suppression of CD4 T cell activation.

Authors:  S M Cruickshank; L D McVay; D C Baumgart; P J Felsburg; S R Carding
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10.

Authors:  E C Ebert; V Mehta; K M Das
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 3.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

Authors:  Taku Kambayashi; Terri M Laufer
Journal:  Nat Rev Immunol       Date:  2014-10-17       Impact factor: 53.106

4.  Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis.

Authors:  Jennifer M Monk; Wooki Kim; Evelyn Callaway; Harmony F Turk; Jennifer E Foreman; Jeffrey M Peters; Weimin He; Brad Weeks; Robert C Alaniz; David N McMurray; Robert S Chapkin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-22       Impact factor: 4.052

5.  Upregulation of Reg 1alpha and GW112 in the epithelium of inflamed colonic mucosa.

Authors:  S Shinozaki; T Nakamura; M Iimura; Y Kato; B Iizuka; M Kobayashi; N Hayashi
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

6.  Relative efficacy of uptake and presentation of Mycobacterium bovis BCG antigens by type I mouse lung epithelial cells and peritoneal macrophages.

Authors:  Mandavi Kumari; Rajiv K Saxena
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

7.  Expression of major histocompatibility complex class II and CD80 by gingival epithelial cells induces activation of CD4+ T cells in response to bacterial challenge.

Authors:  Takashi Matsuyama; Toshihisa Kawai; Yuichi Izumi; Martin A Taubman
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 8.  ICOS costimulation in inflammatory bowel disease.

Authors:  Takanori Kanai; Teruji Totsuka; Katsunari Tezuka; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 9.  Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies.

Authors:  Philip Alex; Marjan Gucek; Xuhang Li
Journal:  Inflamm Bowel Dis       Date:  2009-04       Impact factor: 5.325

10.  Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients.

Authors:  Marcela Medina; Giada De Palma; Carmen Ribes-Koninckx; Miguel Calabuig; Yolanda Sanz
Journal:  J Inflamm (Lond)       Date:  2008-11-03       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.